Hemolytic-uremic syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{HUS}}
{{HUS}}
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{AHS}}


==Overview==
==Overview==
Line 24: Line 24:
==Laboratory Findings==
==Laboratory Findings==


Following Lab findings are seen in HUS:
Following Lab findings are seen in HUS<ref name="pmid26265890">{{cite journal| author=Canpolat N| title=Hemolytic uremic syndrome. | journal=Turk Pediatri Ars | year= 2015 | volume= 50 | issue= 2 | pages= 73-82 | pmid=26265890 | doi=10.5152/tpa.2015.2297 | pmc=4523989 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26265890  }} </ref>:
* '''Microangiopathic Hemolytic Anemia''' with features as follows:
* '''Microangiopathic Hemolytic Anemia''' with features as follows:
** Low Hemoglobin level Often < 10g/dl
** Low Hemoglobin level Often < 10g/dl
Line 31: Line 31:
** Low Haptoglobin level
** Low Haptoglobin level
** Negative Coombs test
** Negative Coombs test
** Peripheral Blood smear shows fragmented RBC's (Schistiocytes, Helmet and Burr calss)
** Peripheral Blood smear shows fragmented RBC's (Schistiocytes, Helmet, and Burr cells)
* '''Thrombocytopenia'''
* '''Thrombocytopenia'''
** Below 150,000 although typically less than 60,000. In spite of low platelet count, active bleeding is rarely seen
** Below 150,000 although typically less than 60,000. In spite of low platelet count, active bleeding is rarely seen
Line 37: Line 37:
** High BUN
** High BUN
** High Creatinine
** High Creatinine
** Electrolyte abnormalities may include Hyponatremia, Hyperkalemia, Hyperphosphatemia, Hypocalcemia and acidosis (resulting from diarrhea, dehydration and renal failure)
** Electrolyte abnormalities may include Hyponatremia, Hyperkalemia, Hyperphosphatemia, Hypocalcemia, and acidosis (resulting from diarrhea, dehydration and renal failure)
** Increased Bilirubin and aminotransferases
** Increased Bilirubin and aminotransferases
** High uric acid levels
** High uric acid levels
Line 49: Line 49:
** Stool culture on Sorbitol MacConkey's agar or Detection of Shiga toxin with serological testing
** Stool culture on Sorbitol MacConkey's agar or Detection of Shiga toxin with serological testing
* '''Genetic Testing'''
* '''Genetic Testing'''
** Done if suspicion of genetic or complement mediated HUS/ recurrent HUS. However results takes weeks-month thus have no role in acute management of disease and treatment should not be delayed while awaiting results
** Done if suspicion of genetic or complement-mediated HUS/ recurrent HUS. However, results take weeks-month thus have no role in the acute management of disease and treatment should not be delayed while awaiting results


==References==
==References==

Revision as of 19:56, 9 August 2018

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome laboratory findings

CDC on Hemolytic-uremic syndrome laboratory findings

Hemolytic-uremic syndrome laboratory findings in the news

Blogs on Hemolytic-uremic syndrome laboratory findings

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anila Hussain, MD [2]

Overview

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal for patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Laboratory Findings

Following Lab findings are seen in HUS[1]:

  • Microangiopathic Hemolytic Anemia with features as follows:
    • Low Hemoglobin level Often < 10g/dl
    • High reticulocyte count
    • Increased LDH level
    • Low Haptoglobin level
    • Negative Coombs test
    • Peripheral Blood smear shows fragmented RBC's (Schistiocytes, Helmet, and Burr cells)
  • Thrombocytopenia
    • Below 150,000 although typically less than 60,000. In spite of low platelet count, active bleeding is rarely seen
  • Serum Chemistry abnormalities
    • High BUN
    • High Creatinine
    • Electrolyte abnormalities may include Hyponatremia, Hyperkalemia, Hyperphosphatemia, Hypocalcemia, and acidosis (resulting from diarrhea, dehydration and renal failure)
    • Increased Bilirubin and aminotransferases
    • High uric acid levels
  • Urinalysis-may show any of following
    • Blood / Red blood cells
    • Protein
    • Bilirubin
    • WBC
    • Casts
  • Stool Testing
    • Stool culture on Sorbitol MacConkey's agar or Detection of Shiga toxin with serological testing
  • Genetic Testing
    • Done if suspicion of genetic or complement-mediated HUS/ recurrent HUS. However, results take weeks-month thus have no role in the acute management of disease and treatment should not be delayed while awaiting results

References

  1. Canpolat N (2015). "Hemolytic uremic syndrome". Turk Pediatri Ars. 50 (2): 73–82. doi:10.5152/tpa.2015.2297. PMC 4523989. PMID 26265890.

Template:WH Template:WS